NCT00169182View on ClinicalTrials.gov

Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

December 15, 2001

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Larynx CancerHypopharynx Cancer
Interventions
DRUG

DOCETAXEL

75 mg/m 2 on day 1

DRUG

Cisplatin

75 mg/m 2 on day 1

DRUG

5-Fluoro-3-Pyridinecarboxylic Acid

750 mg/m 2 by 24-hour continuous infusion for 5 days

Trial Locations (1)

37044

CHU Bretonneau, Tours

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Groupe Oncologie Radiotherapie Tete et Cou

OTHER